Evidence map›Paper›PMID 36012528›Full record

ArticleInternational journal of molecular sciences2022

Attenuation of Autism-like Behaviors by an Anthocyanin-Rich Extract from Portuguese Blueberries via Microbiota-Gut-Brain Axis Modulation in a Valproic Acid Mouse Model.

Diana Serra, Joana F Henriques, Fábio J Sousa, Mariana Laranjo, Rosa Resende, Marisa Ferreira-Marques, Victor de Freitas, Gabriela Silva, João Peça, Teresa C P Dinis and 1 more

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
2.8field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 28 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Review
  6. Review
  7. Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Review
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 1 country.

Diana SerraCNC-Center for Neuroscience and Cell Biology, University of Coimbra, 3004-531 Coimbra, Portugal.ORCID 0000-0002-5965-0281
Joana F HenriquesCNC-Center for Neuroscience and Cell Biology, University of Coimbra, 3004-531 Coimbra, Portugal.ORCID 0000-0003-0102-7988
Fábio J SousaCNC-Center for Neuroscience and Cell Biology, University of Coimbra, 3004-531 Coimbra, Portugal.ORCID 0000-0001-7847-5063
Mariana LaranjoCNC-Center for Neuroscience and Cell Biology, University of Coimbra, 3004-531 Coimbra, Portugal.
Rosa ResendeCNC-Center for Neuroscience and Cell Biology, University of Coimbra, 3004-531 Coimbra, Portugal.ORCID 0000-0002-0504-5756
Marisa Ferreira-MarquesCNC-Center for Neuroscience and Cell Biology, University of Coimbra, 3004-531 Coimbra, Portugal.ORCID 0000-0002-8740-6411
Victor de FreitasREQUIMTE/LAQV-Research Unit, Faculty of Science, Porto University, 4099-002 Porto, Portugal.
Gabriela SilvaCNC-Center for Neuroscience and Cell Biology, University of Coimbra, 3004-531 Coimbra, Portugal.ORCID 0000-0002-7479-8540
João PeçaCNC-Center for Neuroscience and Cell Biology, University of Coimbra, 3004-531 Coimbra, Portugal.
Teresa C P DinisCNC-Center for Neuroscience and Cell Biology, University of Coimbra, 3004-531 Coimbra, Portugal.
Leonor M AlmeidaCNC-Center for Neuroscience and Cell Biology, University of Coimbra, 3004-531 Coimbra, Portugal.
University of Coimbra · PTEscola Universitária Vasco da Gama · PTRede de Química e Tecnologia · PT

Funding

Fundação para a Ciência e Tecnologia LA/P/0058/2020Fundação para a Ciência e Tecnologia POCI-01-0145-FEDER-029089Fundação para a Ciência e Tecnologia PTDC/MED-NEU/5993/2020Fundação para a Ciência e Tecnologia UIDB/04539/2020Fundação para a Ciência e Tecnologia UIDP/04539/2020
6 · The paper itself

Abstract

Autism Spectrum Disorders (ASDs) are a group of neurodevelopmental pathologies whose current treatment is neither curative nor effective. Anthocyanins are naturally occurring compounds abundant in blueberries and in other red fruits which have been shown to be successful in the treatment of several neurological diseases, at least in in vitro and in vivo disease models. The aim of the present work was to study the ability of an anthocyanin-rich extract (ARE) obtained from Portuguese blueberries to alleviate autism-like symptoms in a valproic acid (VPA) mouse model of ASD and to get insights into the underlying molecular mechanisms of such benefits. Therefore, pregnant BALB/c females were treated subcutaneously with a single dose of VPA (500 mg/kg) or saline on gestational day 12.5. Male offspring mice were orally treated with the ARE from Portuguese blueberries (30 mg/kg/day) or the vehicle for three weeks, and further subjected to behavioral tests and biochemical analysis. Our data suggested that the ARE treatment alleviated autism-like behaviors in in utero VPA-exposed mice and, at the same time, decreased both neuroinflammation and gut inflammation, modulated the gut microbiota composition, increased serotonin levels in cerebral prefrontal cortex and gut, and reduced the synaptic dysfunction verified in autistic mice. Overall, our work suggests that anthocyanins extracted from Portuguese blueberries could constitute an effective strategy to ameliorate typical autistic behaviors through modulation of the microbiota-gut-brain axis.

Indexed as

Autism Spectrum DisorderAutistic DisorderBlueberry PlantsGastrointestinal MicrobiomePrenatal Exposure Delayed EffectsAnimalsAnthocyaninsBrain-Gut AxisDisease Models, AnimalFemaleHumansMaleMiceMice, Inbred BALB CPortugalPregnancyAnthocyaninsValproic Acidanthocyaninsautism-like behaviorsAutism Spectrum Disordergut microbiotamicrobiota–gut–brain axisneuroinflammationvalproic acid

Identifiers

PMID36012528
PMCPMC9409076
OpenAlexW4292164073

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.